We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
76
Automatic Data Processing
ADP
$106B
$44.3M 0.31%
216,096
+35,296
+20% +$7.96M
MS icon
77
Morgan Stanley
MS
$333B
$43.3M 0.3%
536,271
-124,815
-19% -$11.6M
ZTO icon
78
ZTO Express
ZTO
$18.2B
$42.9M 0.3%
+1,627,230
New +$44.4M
ELV icon
79
Elevance Health
ELV
$83.7B
$42.9M 0.3%
101,375
-7,614
-7% -$3.62M
MDLZ icon
80
Mondelez International
MDLZ
$80.2B
$42.6M 0.3%
664,075
+112,169
+20% +$7.43M
CTAS icon
81
Cintas
CTAS
$86B
$42.1M 0.29%
395,264
+171,188
+76% +$18.9M
ILMN icon
82
Illumina
ILMN
$29.2B
$41.7M 0.29%
200,396
-48,131
-19% -$9.85M
SEDG icon
83
SolarEdge
SEDG
$2.44B
$41.6M 0.29%
148,724
+29,135
+24% +$8.88M
SYK icon
84
Stryker
SYK
$133B
$40.9M 0.28%
155,486
+9,305
+6% +$2.47M
SBUX icon
85
Starbucks
SBUX
$118B
$40.5M 0.28%
422,346
-36,062
-8% -$3.75M
STKL
86
DELISTED
SunOpta
STKL
$40M 0.28%
5,673,614
+5,621,425
+10,771% +$45M
OC icon
87
Owens Corning
OC
$11.5B
$39.1M 0.27%
443,768
-238,591
-35% -$22.6M
ICE icon
88
Intercontinental Exchange
ICE
$86.4B
$39.1M 0.27%
407,205
+163,731
+67% +$17.1M
NBIX icon
89
Neurocrine Biosciences
NBIX
$18.4B
$38.9M 0.27%
417,180
+148,008
+55% +$15.4M
AZN icon
90
AstraZeneca
AZN
$267B
$38.8M 0.27%
304,026
+4,754
+2% +$640K
BIO icon
91
Bio-Rad Laboratories Class A
BIO
$8.86B
$37.1M 0.26%
84,075
-2,403
-3% -$1.12M
BZ icon
92
Kanzhun
BZ
$7.07B
$36.9M 0.26%
+2,106,130
New +$45.9M
CL icon
93
Colgate-Palmolive
CL
$74.2B
$36.8M 0.26%
531,945
-22,435
-4% -$1.67M
UPS icon
94
United Parcel Service
UPS
$89.7B
$36.6M 0.25%
204,959
+11,090
+6% +$2.03M
CMCSA icon
95
Comcast
CMCSA
$85.8B
$36.5M 0.25%
1,046,961
+677,799
+184% +$25.6M
TTEK icon
96
Tetra Tech
TTEK
$8.7B
$36.5M 0.25%
1,349,205
+327,870
+32% +$9.47M
PEP icon
97
PepsiCo
PEP
$195B
$35.7M 0.25%
212,607
+23,081
+12% +$4.03M
TJX icon
98
TJX Companies
TJX
$178B
$35.6M 0.25%
493,617
+69,403
+16% +$5.46M
CVS icon
99
CVS Health
CVS
$140B
$35.4M 0.25%
517,712
-169,870
-25% -$14.2M
OLED icon
100
Universal Display
OLED
$3.85B
$35.3M 0.24%
247,048
-10,450
-4% -$1.4M

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.